REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI (NCT05246098)
REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or Acute Respiratory Infection
🩺 Plain-English Summary (8th-Grade Level)
Background: Many adults and some children with COVID-19 or acute respiratory infection become critically ill and need advanced life support in the Intensive Care Unit (ICU). Frailty is a medical condition of reduced function and health. Adults with frailty have a lower chance of surviving critical illness. The investigators are still learning about critically ill adults with COVID-19 or acute respiratory infection, and do not have much information on how frailty affects outcomes in critically ill children, with or without COVID-19 or acute respiratory infection. Rehabilitation can help survivors of COVID-19 or acute respiratory infection by improving strength and improve quality of life (QOL). Objectives: The main goal of this research study is to see if patients with frailty have a lower chance of surviving COVID-19 or acute respiratory infection critical illness and more health problems after survival than patients without frailty. The investigators will also study the types of rehabilitation received by patients with COVID-19 or acute respiratory infection. Methods: The investigators will include adults and children with COVID-19 or acute respiratory infection who are admitted to the ICUs that participate in the study. The investigators will gather data about each patient, including before and during their illness. Outcomes: The investigators will collect level of frailty, function, and types of therapy, or rehabilitation received by patients. In adults, the investigators are most interested in learning if frailty influences mortality, or death. In children, the investigators are most interested in whether children with COVID-19 or acute respiratory infection critical illness are more likely to develop frailty. The investigators will also study post-hospital discharge location in survivors (e.g., home, rehabilitation). Relevance: The COVID-19 pandemic is a global public health crisis. It is critical to understand how COVID-19 and other acute respiratory infection critical illness affects groups of people who are at higher risk, and the impact on outcomes that are important to patients, like functioning and QOL. The results will help policy makers plan post-hospital services for survivors, help healthcare workers understand the importance of rehabilitation practice for patients with COVID-19 or acute respiratory infection, and help researchers develop treatments to improve QOL after COVID-19 or acute respiratory infection.
Who can join: Review the eligibility criteria below.
Location: Alberta Children's Hospital — Calgary, Alberta
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (28 Sites)
Showing the first 25 of 28 sites.
- Alberta Children's Hospital — Calgary, Alberta
- University of Alberta — Edmonton, Alberta
- Sturgeon Community Hopsital — St. Albert, Alberta
- Royal Columbian Hospital — New Westminster, British Columbia
- Children's Hospital of Winnipeg — Winnipeg, Manitoba
- QEII Health Sciences Centre — Halifax, Nova Scotia
- Izaak Walton Killam Hospital for Children — Halifax, Nova Scotia
- Brantford General Hospital — Brantford, Ontario
- Hamilton General Hospital — Hamilton, Ontario
- St. Joseph's Healthcare Intensive Care Unit — Hamilton, Ontario
- McMaster Children's Hospital — Hamilton, Ontario
- Juravinski Hospital — Hamilton, Ontario
- Kingston Health Sciences Centre — Kingston, Ontario
- London Health Sciences Centre — London, Ontario
- Children's Hospital of Eastern Ontario — Ottawa, Ontario
- The Ottawa Hospital — Ottawa, Ontario
- Niagara Health System — St. Catharines, Ontario
- Sunnybrook Hospital — Toronto, Ontario
- St. Michael's Hospital — Toronto, Ontario
- The Hospital for Sick Children — Toronto, Ontario
- Hôpital Hôtel-Dieu de Lévis — Lévis, Quebec
- Centre hospitalier de l'Université de Montréal — Montreal, Quebec
- The Centre hospitalier universitaire Sainte-Justine — Montreal, Quebec
- Montreal Children's Hospital — Montreal, Quebec
- Hôpital du Sacré-Cœur de Montréal — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (905) 522-1155
Email: revive@mcmaster.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Respiratory Disease
- Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention — Baltimore, Maryland
- Measures of Respiratory Health Registry — Vancouver, British Columbia
- Imaging Measures of Respiratory Health Registry — Vancouver, British Columbia
Explore by condition: All Respiratory Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.